{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T23:12:45Z","timestamp":1719443565749},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T00:00:00Z","timestamp":1565568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Great Eastern Drug"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s40120-019-00150-x","type":"journal-article","created":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T12:03:41Z","timestamp":1565611421000},"page":"425-431","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can Generic Intravenous Levetiracetam Be Used for Acute Repetitive Convulsive Seizure or Status Epilepticus? A Randomized Controlled Trial"],"prefix":"10.1007","volume":"8","clinical-trial-number":[{"clinical-trial-number":"tctr20190513001","registry":"10.18810\/tctr"}],"author":[{"given":"Rachot","family":"Wongjirattikarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittisak","family":"Sawanyawisuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sineenard","family":"Pranboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriporn","family":"Tiamkao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somsak","family":"Tiamkao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"150_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cns.12389","volume":"22","author":"A Bachhuber","year":"2016","unstructured":"Bachhuber A, Lasrich M, Halmer R, Fassbender K, Walter S. Comparison of antiepileptic approaches in treatment of benzodiazepine nonresponsive status epilepticus. CNS Neurosci Ther. 2016;22:178\u201383.","journal-title":"CNS Neurosci Ther"},{"key":"150_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","volume":"14","author":"JP Betjemann","year":"2015","unstructured":"Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015;14:615\u201324.","journal-title":"Lancet Neurol."},{"key":"150_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.yebeh.2016.09.030","volume":"64","author":"F Brigo","year":"2016","unstructured":"Brigo F, Bragazzni N, Nardone R, Trinka E. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav. 2016;64:110\u20135.","journal-title":"Epilepsy Behav"},{"key":"150_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11940-016-0394-5","volume":"18","author":"EH Grover","year":"2016","unstructured":"Grover EH, Nazzal Y, Hirsch LJ. Treatment of convulsive status epilepticus. Curr Treat Opt Neurol. 2016;18:11\u201331.","journal-title":"Curr Treat Opt Neurol."},{"key":"150_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.eplepsyres.2015.04.013","volume":"114","author":"RC Mundlamuri","year":"2015","unstructured":"Mundlamuri RC, Sinha S, Subbakrishna DK, Prathyusha PV, Nagappa M, Bindu PS, et al. Management of generalized convulsive status epilepticus (SE): a prospective randomized controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam\u2014pilot study. Epilepsy Res. 2015;114:52\u20138.","journal-title":"Epilepsy Res"},{"key":"150_CR6","first-page":"634","volume":"59","author":"P Lewek","year":"2010","unstructured":"Lewek P, Kardas P. Generic drugs: the benefits and risks of making the switch. J Fam Pract. 2010;59:634\u201340.","journal-title":"J Fam Pract"},{"key":"150_CR7","first-page":"403","volume":"55","author":"S Hahn","year":"2012","unstructured":"Hahn S. Understanding noninferiority trials. Korean. J Pediatr. 2012;55:403\u20137.","journal-title":"J Pediatr"},{"key":"150_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.eplepsyres.2015.04.003","volume":"114","author":"MM Atmaca","year":"2015","unstructured":"Atmaca MM, Orhan EK, Bebek N, Gurses C. Intravenous levetiracetam treatment in status epilepticus: a prospective study. Epilepsy Res. 2015;114:13\u201322.","journal-title":"Epilepsy Res"},{"key":"150_CR9","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jocn.2014.12.013","volume":"22","author":"S Chakravarthi","year":"2015","unstructured":"Chakravarthi S, Goyal MK, Modi M, Bhalla A, Singh P. Levetiracetam versus phenytoin in management of status epilepticus. J Clin Neurosci. 2015;22:959\u201363.","journal-title":"J Clin Neurosci."},{"key":"150_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ejpn.2015.02.010","volume":"19","author":"C Khongkhatithum","year":"2015","unstructured":"Khongkhatithum C, Thampratankul L, Wiwattanadittakul N, Visudtibhan A. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures. Eur J Paediatr Neurol. 2015;19:429\u201334.","journal-title":"Eur J Paediatr Neurol."},{"key":"150_CR11","first-page":"167","volume":"18","author":"S Thongplew","year":"2013","unstructured":"Thongplew S, Chawsamtong S, Sawanyawisuth K, Tiamkao S. Intravenous levetiracetam treatment in Thai adults with status epilepticus. Neurol Asia. 2013;18:167\u201375.","journal-title":"Neurol Asia."}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-019-00150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-019-00150-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-019-00150-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T14:13:57Z","timestamp":1711721637000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-019-00150-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,12]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["150"],"URL":"https:\/\/doi.org\/10.1007\/s40120-019-00150-x","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,12]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}